Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

April 30, 2015

Conditions
Metastatic Renal Cell Carcinoma
Interventions
DRUG

Pazopanib

Non interventional study

Trial Locations (34)

28007

Hospital Gregorio Marañon, Madrid

Unknown

Hospital Son Espases, Palma de Mallorca

Hospital Clínic de Barcelona, Barcelona

Hospital Vall d' Hebron, Barcelona

Hospital San Pedro de Alcántara, Cáceres

Hospital G U de Ciudad Real, Ciudad Real

Hospital Reina Sofía, Córdoba

Hospital Universitario de Donostia, Donostia / San Sebastian

Hospital San Cecilio, Granada

Hospital General Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria

Hospital de León, León

Hospital San Pedro Logroño, Logroño

Hospital Lucus Augusti, Lugo

Fundacion Jimenez Diaz, Madrid

Hospital Clínico San Carlos, Madrid

Hospital Quirón, Madrid

Hospital U Puerta de Hierro Majadahonda, Madrid

Hospital Universitario 12 de Octubre, Madrid

Hospital Universitario La Paz, Madrid

Hospital Provincial de Pontevedra, Pontevedra

Hospital Clínico Universitario Salamanca, Salamanca

Hospital Universitario de Canarias, Santa Cruz de Tenerife

Hospital Marques de Valdecilla, Santander

Hospital Ntra. Sra. De Valme, Seville

Hospital Universitario Virgen del Rocío, Seville

Hospital Virgen de la Salud, Toledo

Hospital Clínico de Valencia, Valencia

Hospital Gral Universitario Valencia, Valencia

Hospital Universitario Dr. Peset, Valencia

IVO Valencia, Valencia

Hospital Rio Hortega, Valladolid

CHUVI ( Vigo), Vigo

Hospital Lozano Blesa, Zaragoza

Hospital Miguel Servet, Zaragoza

All Listed Sponsors
lead

Spanish Oncology Genito-Urinary Group

OTHER

NCT02282579 - Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy | Biotech Hunter | Biotech Hunter